SCHEMBL19639709

SCHEMBL19639709

Cc1cn(C(F)(F)F)c(=O)[nH]c1=O

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ TK1 P04183 5/20 0.38
▸ TK2 O00142 2/20 0.38
▸ TYMP P19971 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ALB P02768 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910660 0.83 MAPK1 (0.44) MAPK1HPGDTK1TK2TYMP
SCHEMBL9753003 0.76 LMNA (0.40) HPGDALDH1A1LMNAADRA1A
SCHEMBL22260407 0.76 MAPK1 (0.42) MAPK1HPGDTK1TK2TYMP
SCHEMBL20222500 0.76 MAPK1 (0.42) MAPK1HPGDTK1TK2TYMP
SCHEMBL9021548 0.74 TK1 (0.39) MAPK1HPGDTK1TK2TYMP
SCHEMBL22020875 0.73 MAPK1 (0.41) MAPK1HPGDTK1TK2TYMP
SCHEMBL26793575 0.73 MAPK1 (0.41) MAPK1HPGDTK1TK2TYMP
SCHEMBL27621506 0.72 MAPK1 (0.46) MAPK1HPGDTK1TYMPALDH1A1
SCHEMBL22198654 0.71 TK1 (0.39) MAPK1HPGDTK1TK2TYMP
SCHEMBL21090689 0.71 TK1 (0.39) MAPK1HPGDTK1TK2TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112933103-B Cytidine trifluoride and tipyrimidine hydrochloride combination and application 江苏集萃分子工程研究院有限公司 2022-09-16 — — CN disclosed
CN-112933103-A Cytidine trifluoride and tipyrimidine hydrochloride combination and application 江苏集萃分子工程研究院有限公司 2021-06-11 — — CN disclosed
US-20170342386-A1 REPROGRAMMING OF SOMATIC CELLS WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 2017-11-30 — — US disclosed
Send feedback